Healthy volunteers test two injection devices for drug delivery

NCT ID NCT06475729

First seen Jan 05, 2026 · Last updated May 12, 2026 · Updated 25 times

Summary

This study looked at how well two different autoinjectors deliver the drug mirikizumab into the bloodstream of healthy people. About 500 healthy adults received a single injection under the skin using either a standard 1-mL autoinjector or a newer 2-mL version. The goal was to see if the two devices work the same way, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CenExel ACT

    Anaheim, California, 92801, United States

  • Clinical Pharmacology of Miami

    Miami, Florida, 33014-3616, United States

  • Fortrea Clinical Research Unit

    Daytona Beach, Florida, 32117, United States

  • Fortrea Clinical Research Unit

    Dallas, Texas, 75247, United States

  • Fortrea Clinical Research Unit

    Madison, Wisconsin, 53704, United States

  • QPS Missouri

    Springfield, Missouri, 65802, United States

Conditions

Explore the condition pages connected to this study.